Korean J Thorac Cardiovasc Surg.  2004 Mar;37(3):228-234.

Surgical Management of Primary Cardiac Tumor: Early and Late Results

Affiliations
  • 1Department of Thoracic and Cardiovascular Surgery, Ajou University Hospital, Korea. cjlee@ajou.ac.kr
  • 2Department of Thoracic and Cardiovascular Surgery, Ajou University Hospital, Nurse Practitioner, Korea.

Abstract

BACKGROUND: Primary cardiac tumors are rare disease and they present nonspecific symptom. They are divided in benign and malignant tumors and require surgical therapy and/or additional therapy. MATERIAL AND METHOD: From March 1995 to March 2003, twenty one patients were diagnosed as having primary cardiac tumors. We analysed them retrospectively in terms of various perioperative factors and early and late results. RESULT: 6 men and 15 women and their average age was 45.44+/-18.76. Pathology revealed eighteen benign (fourteen myxoma, two fibroelastoma, one hemangioma and one paraganglioma) disease and three malignant (one angiosarcoma, one mesothelioma and one myxofibrosarcoma) disease. There was one (myxoma) operative mortality and three late death (hemangioma, angiosarcoma and mesothelioma) during additional therapy and follow up.
CONCLUSION
Surgical treatment of primary cardiac tumor is important and sometimes additional therapy is required but the prognosis of malignant cardiac tumor is still very poor.

Keyword

Heart neoplasms; Neoplasm outcomes

MeSH Terms

Female
Follow-Up Studies
Heart Neoplasms*
Hemangioma
Hemangiosarcoma
Humans
Male
Mesothelioma
Mortality
Myxoma
Pathology
Prognosis
Rare Diseases
Retrospective Studies
Full Text Links
  • KJTCS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr